Shishir Shah
DO, CWS, ABPM

Dr. Shah has over 25 years of experience in health care, biotechnology, and strategic business development. He received his B.S. in Aeronautical Engineering from Rensselaer Polytechnic Institute and a Doctorate in Osteopathic Medicine from Midwestern University. He started his career as a systems analyst for JPL/NASA. Before medical school, Dr. Shah worked as a managing director for Ramblax and Co., an investment-banking boutique, where he was closely involved in business development strategies for mobile telecom startups. He subsequently worked in biomedical product design and pharmaceutical packaging operations with Becton Dickinson Co. During his medical training, Dr. Shah specialized in Emergency Medicine and Family Practice. Upon completion of his training, he provided clinical health care at several outpatient and emergency room facilities in Illinois, Indiana, and Arizona. He has also served as a consultant at CIGNA Healthcare where he was involved in cost containment for high-end patient utilization and staff turnover reduction. Dr. Shah has received additional training in wound management and board certification in hyperbaric medicine. He has co-implemented one of the largest wound care /hyperbaric clinical delivery models in the U.S. and works in several advisory roles for hospitals, startups, pharmaceutical/medical device companies, and legal firms. After selling his medical group to a publicly-traded company- Team Health (later acquired by Blackstone Group), he remains as the medical director for the Advanced Wound Care and Hyperbaric Medicine Center at a level I trauma center in Phoenix, AZ and the Chief Medical Office of R3 Hyperbarics in Texas. He does extensive consulting for pharmaceutical/medical device companies, utilization review for California workman’s compensation, medical products, Medicare-related chart review, and national speaking engagements involving medical devices and pharmaceuticals. Also, he has recently joined 3 Rivers Capital – Private Equity. As an operating partner, he plays a key role in due diligence and investor presentations to raise debt and equity financing in acquiring target companies in the outpatient health specialty segment. His additional duties include marketing, business development, insurance negotiation, management hires, and new deal analysis.

Sessions

Register
Pre Conference

Preconference Industry Supported Symposium: Debridement Day

Wednesday, March 20, 2024
1:30 PM - 2:30 PM
Non-CME Innovation Theater

Preconference Innovation Theater: Introducing UrgoClean Ag: The First and Only Dressing that Supports the Continuous Debridement of Slough (Non-Accredited)

Thursday, March 21, 2024
1:30 PM - 2:00 PM